Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
US11338046B2 · kind B2 · utility
0Cited by
3References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 22, 2017 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Jan 7, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides new adeno-associated virus-derived vectors and pharmaceutical compositions containing the same for the treatment of lysosomal storage disorders and specially, for the treatment of mucopolysaccharidoses Type IIID.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.